Cardiff Lexington Q2 2026: Going Concern Warning, Widening Losses, and Toxic Debt
CDIX sits 50% above its 52-week low of $0.4.
Summary
Cardiff Lexington's Q2 2026 filing shows a going concern warning, a 23% revenue decline, a $5.57M net loss, and only $218K in cash. Toxic convertible debt and a new equity line threaten massive dilution.
Key Events · Earnings and Guidance · CDIX
-
Going Concern Warning
Management states substantial doubt about the company's ability to continue as a going concern, citing an accumulated deficit of $85.6 million and negative operating cash flow of $668,649 for the first half of 2026.
-
Widening Losses
Net loss attributable to common shareholders was $6.13 million for H1 2026, up from $2.18 million in H1 2025. Revenue declined 23% to $4.38 million, while interest expense surged to $4.05 million.
-
Toxic Convertible Debt
The company has $1.36 million in convertible notes with variable conversion prices, reset features, and default penalties. Derivative liabilities of $1.09 million were recognized, and the notes could cause severe dilution if converted.
-
Equity Line of Credit
A $75 million Common Stock Purchase Agreement with Leonite Fund I, LP was disclosed, with the first draw of $30,000 in July 2026. The agreement allows the company to sell shares at a discount, providing liquidity but at the cost of significant dilution.
Analysis · CDIX · Industrial Applications And Services
The Q2 2026 10-Q from Cardiff Lexington paints a picture of rapidly deteriorating finances. Revenue dropped 23% year-over-year to $4.38 million, while the net loss ballooned to $5.57 million from $1.68 million a year ago, driven by surging interest expense on its credit line and new convertible debt. With only $218,000 in cash against $26.6 million in current liabilities, management explicitly warns of substantial doubt about the company's ability to continue as a going concern. The balance sheet is loaded with toxic convertible notes carrying variable conversion prices, reset features, and default penalties that could massively dilute existing shareholders. Adding legal uncertainty, a lawsuit by the former chairman seeks unspecified damages. The filing also discloses a $75 million equity line of credit with Leonite Fund I, LP, which began drawing in July — a lifeline that comes with heavy dilution risk. This is a critical update that materially alters the investment thesis.
At the time of this filing, CDIX was trading at $0.60 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9.4M. The 52-week trading range was $0.40 to $315.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.